In the combinational therapy, the Treg cells in the tumor were decreased from 13.2% to 6.8%, the CD8+ T effector cells significantly elevated, and the secretion of proinflammatory cytokines IFN-γ and TNF-α was significantly increased [34]. The gene discussed is CD8A; the disease is neoplasm.